B
BDRX
Biodexa Pharmaceuticals plc
5.71
0.13+2.33%After Hours: 5.82 +0.11 +1.93%19:02 08/27 EDT
OPEN/PREV CLOSE5.84/5.58
TODAY RANGE5.55-6.16
VOL22.00K
MARKET CAP3.54M
52 WEEK RANGE5.53-160.00
AVG VOL (3M)155.78K
% TURNOVER3.55%
TURNOVER--
P/E (TTM)-0.0039
% RANGE10.80%
EPS(TTM)-1,451.1958
P/E(FORWARD)-0.2766
P/B0.0001
BVPS39,040.14
DIVIDEND--
P/S559.80
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP3.50M
SHARES OUTSTANDING619.52K
NEXT EARNINGS09/22-10/04
FREE FLOAT613.62K
LOT SIZE1
EX-DATE07/31/2025
News
Press Releases
Financial Reports
Profile
TipRanks·08/18 12:57
Biodexa Pharmaceuticals Begins Phase 3 Trial for FAP Treatment
TipRanks·08/18 12:35
Biodexa announces enrollment of first two patients in Phase 3 Serenta trial
TipRanks·07/31 13:59
Biodexa Pharmaceuticals Implements ADR Ratio Change
TipRanks·07/30 23:50
Biodexa Pharmaceuticals PLC-ADR trading halted, news pending
TipRanks·07/27 12:46
Upcoming Stock Splits This Week (July 28 to August 1) – Stay Invested
TipRanks·07/15 20:56
Biodexa Pharmaceuticals Announces ADR Ratio Change Effective July 31, 2025
Seeking Alpha·07/15 20:49
Biodexa Pharmaceuticals announces 1-for-10 reverse ADR split to regain Nasdaq compliance
TipRanks·07/14 12:35
Biodexa Pharmaceuticals files CTA in Europe for Phase 3 Serenta trial
TipRanks·06/27 21:19
Biodexa Pharmaceuticals Announces Successful AGM Resolutions
TipRanks·06/25 12:35
Biodexa announces activation of first clinical study site for Serenta trial
Same Industry
Name/Symbol
Change%
Price